Literature DB >> 22757650

The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability.

I R Sequeira1, R G Lentle, M C Kruger, R D Hurst.   

Abstract

BACKGROUND: We explored the temporal dynamics of the lactulose mannitol test and the influence of a single dose of aspirin.
METHODS: Twenty healthy female volunteers each received 600 mg aspirin or placebo in random sequence and were subsequently dosed with 10 g lactulose and 5 g mannitol, their urine collected every half hour for 6h. KEY
RESULTS: The lactulose:mannitol ratios (LMR) of urine samples collected over the entire 6-h period were significantly higher than those collected in the first 3 h. Greater quantities of mannitol were excreted over the first than the subsequent 3 h. A similar pattern of temporal variation in mannitol excretion was found in smokers and non-smokers and was maintained following administration of a single 600 mg dose of aspirin. The rates at which lactulose was excreted were relatively constant over the entire 6 h period of collection, but mean levels were increased over the entire 6 h following the administration of aspirin. The effect of aspirin did not differ significantly between smokers and non-smokers. CONCLUSIONS & INFERENCES: While the LMR test is sufficiently sensitive to reproducibly detect the increase in intestinal permeability resulting from a single 600 mg oral dose of aspirin, the temporal patterns of excretion of mannitol and lactulose differ both in the presence and absence of aspirin. Hence, variation in sampling period and in method of dosage are likely to influence the result and it is preferable to examine the patterns of absorption of component sugars separately with due regard to the method of dosage.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22757650     DOI: 10.1111/j.1365-2982.2012.01969.x

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  6 in total

1.  (13) C mannitol as a novel biomarker for measurement of intestinal permeability.

Authors:  M Grover; M Camilleri; J Hines; D Burton; M Ryks; A Wadhwa; W Sundt; R Dyer; R J Singh
Journal:  Neurogastroenterol Motil       Date:  2016-02-23       Impact factor: 3.598

2.  Mucosal permeability testing: should interpretation change or stay the same?

Authors:  D S Rafati; R J Shulman
Journal:  Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 3.598

3.  A Simple, Robust, and Convenient HPLC Assay for Urinary Lactulose and Mannitol in the Dual Sugar Absorption Test.

Authors:  Ivana R Sequeira; Marlena C Kruger; Roger D Hurst; Roger G Lentle
Journal:  Molecules       Date:  2022-04-21       Impact factor: 4.927

4.  Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.

Authors:  Ivana R Sequeira; Roger G Lentle; Marlena C Kruger; Roger D Hurst
Journal:  PLoS One       Date:  2015-12-02       Impact factor: 3.240

6.  Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.

Authors:  Andrés Acosta; Michael Camilleri; Andrea Shin; Sara Linker Nord; Jessica O'Neill; Amber V Gray; Alan J Lueke; Leslie J Donato; Duane D Burton; Lawrence A Szarka; Alan R Zinsmeister; Pamela L Golden; Anthony Fodor
Journal:  Clin Transl Gastroenterol       Date:  2016-05-26       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.